Godfrey Phillips India Reports Record Profit Surge; Inks Strategic Deal

Godfrey Phillips India Ltd, a cigarette manufacturer, reported a significant 86% increase in net profit for the fourth quarter of FY26, largely due to strong sales. The company's board also announced a new distribution agreement for nicotine replacement therapy products with Aspeya India Pvt Ltd.

In a notable financial achievement, Godfrey Phillips India Ltd has reported a remarkable 86% surge in its consolidated net profit for Q4 of FY26, amounting to Rs 521.46 crore. This considerable increase is attributed to robust sales performance, the company revealed in its recent regulatory filing.

Comparatively, the company had recorded a net profit of Rs 279.61 crore in the same quarter of the previous fiscal year. The total revenue from operations witnessed a significant leap to Rs 3,485.54 crore in Q4FY26, up from Rs 1,887.79 crore year-on-year, while total expenses also increased over the period.

Additionally, the board of directors has announced a final dividend of Rs 3.3 per equity share and approved a strategic distribution agreement with Aspeya India Pvt Ltd. This deal will see GPI distributing nicotine replacement therapy products, underlining the company's strategic growth objectives.